0001531209-18-000003.txt : 20181226 0001531209-18-000003.hdr.sgml : 20181226 20181226145152 ACCESSION NUMBER: 0001531209-18-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181226 DATE AS OF CHANGE: 20181226 EFFECTIVENESS DATE: 20181226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Entrada Therapeutics, Inc. CENTRAL INDEX KEY: 0001689375 IRS NUMBER: 813983399 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-328899 FILM NUMBER: 181252458 BUSINESS ADDRESS: STREET 1: C/O FOLEY HOAG LLP STREET 2: 155 SEAPORT BLVD. CITY: BOSTON STATE: MA ZIP: 02210-2600 BUSINESS PHONE: 857-305-1825 MAIL ADDRESS: STREET 1: C/O FOLEY HOAG LLP STREET 2: 155 SEAPORT BLVD. CITY: BOSTON STATE: MA ZIP: 02210-2600 FORMER COMPANY: FORMER CONFORMED NAME: CycloPorters, Inc. DATE OF NAME CHANGE: 20161104 D 1 primary_doc.xml X0708 D LIVE 0001689375 Entrada Therapeutics, Inc. c/o Foley Hoag LLP 155 Seaport Blvd. Boston MA MASSACHUSETTS 02210-2600 857-305-1825 DELAWARE CycloPorters, Inc. Corporation true 2016 Louis Tartaglia c/o Foley Hoag LLP 155 Seaport Blvd. Boston MA MASSACHUSETTS 02210-2600 Director Kush Parmar c/o Foley Hoag LLP 155 Seaport Blvd. Boston MA MASSACHUSETTS 02210-2600 Director Dehua Pei c/o Foley Hoag LLP 155 Seaport Blvd. Boston MA MASSACHUSETTS 02210-2600 Director Anja Harmeier c/o Foley Hoag LLP 155 Seaport Blvd. Boston MA MASSACHUSETTS 02210-2600 Director Dipal Doshi c/o Foley Hoag LLP 155 Seaport Blvd. Boston MA MASSACHUSETTS 02210-2600 Executive Officer Director Natarajan Sethuraman c/o Foley Hoag LLP 155 Seaport Blvd. Boston MA MASSACHUSETTS 02210-2600 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2018-12-14 true true false 0 59021750 34021752 24999998 Total Offering Amount and Total Amount Sold include the conversion of outstanding indebtedness of the Issuer. A portion of the offering amount is reserved for additional closings. false 10 0 0 645000 true The above figure is an estimate of payments for services in the ordinary course expected to be made over the course of one year. false Entrada Therapeutics, Inc. /s/ Dipal Doshi Dipal Doshi President & CEO 2018-12-22